Trial Profile
A Multicenter Trial of the Efficacy and Safety of Diclegis for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxylamine/pyridoxine (Primary)
- Indications Morning sickness
- Focus Therapeutic Use
- Sponsors Duchesnay Inc
- 22 Nov 2021 Status changed from active, no longer recruiting to discontinued.
- 14 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Sep 2017.
- 14 Apr 2017 Status changed from recruiting to active, no longer recruiting.